FDA, EU diverge on AstraZeneca COVID-19 vaccine

FDA, EU diverge on AstraZeneca COVID-19 vaccine

on Also in ,
The FDA has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists

Share:

Previous
Next

Comentarios

Publicar un comentario

Leave a comment. Thanks!

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)